Bimoclomol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBimoclomol
Drug Alias Name氯吡哌醇ABT-822BRLP-42BRX-211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein biosynthesis stimulants
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrphazyme A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrphazyme A/S
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A